---
document_datetime: 2023-09-21 21:17:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/procysbi-epar-all-authorised-presentations_en.pdf
document_name: procysbi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8734962
conversion_datetime: 2025-12-19 11:16:15.988885
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form            | Route of Administration   | Immediate Packaging   | Pack size    |
|------------------|-------------------|------------|--------------------------------|---------------------------|-----------------------|--------------|
| EU/1/13/861/001  | Procysbi          | 25 mg      | Gastro-resistant capsule, hard | Oral use                  | bottle (HDPE)         | 60 capsules  |
| EU/1/13/861/002  | Procysbi          | 75 mg      | Gastro-resistant capsule, hard | Oral use                  | bottle (HDPE)         | 250 capsules |
| EU/1/13/861/003  | Procysbi          | 75 mg      | Gastro-resistant granules      | Oral use                  | sachet (PET/alu/LDPE) | 120 sachets  |
| EU/1/13/861/004  | Procysbi          | 300 mg     | Gastro-resistant granules      | Oral use                  | sachet (PET/alu/LDPE) | 120 sachets  |